Blaney; Joseph E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blaney; Joseph E..The latest application filed is for "development of dengue virus vaccine components".

Company Profile

7.25.20

Blaney; Joseph E. - Gettysburg PA
Blaney; Joseph E. - Frederick MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Development Of Dengue Virus Vaccine Components App 20220251521 - Whitehead; Stephen S. ; et al.	2022-08-11
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 11,400,150 - Pletnev , et al. August 2, 2	2022-08-02
Development of dengue virus vaccine components Grant 11,332,722 - Whitehead , et al. May 17, 2	2022-05-17
Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein Grant 11,318,196 - Whitehead , et al. May 3, 2	2022-05-03
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20210069317 - Pletnev; Alexander G. ; et al.	2021-03-11
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,869,920 - Pletnev , et al. December 22, 2	2020-12-22
Multivalent vaccines for rabies virus and filoviruses Grant 10,849,975 - Blaney , et al. December 1, 2	2020-12-01
Development Of Dengue Virus Vaccine Components App 20200318083 - Whitehead; Stephen S. ; et al.	2020-10-08
Development of dengue virus vaccine components Grant 10,724,007 - Whitehead , et al.	2020-07-28
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20200085939 - Whitehead; Stephen S. ; et al.	2020-03-19
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile App 20200030435 - Pletnev; Alexander G. ; et al.	2020-01-30
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant 10,500,264 - Whitehead , et al. Dec	2019-12-10
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,456,461 - Pletnev , et al. Oc	2019-10-29
Development Of Dengue Virus Vaccine Components App 20190119654 - Whitehead; Stephen S. ; et al.	2019-04-25
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20180369358 - Pletnev; Alexander G. ; et al.	2018-12-27
Development of dengue virus vaccine components Grant 10,160,957 - Whitehead , et al. Dec	2018-12-25
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,058,602 - Pletnev , et al. August 28, 2	2018-08-28
Development Of Dengue Virus Vaccine Components App 20180171308 - Whitehead; Stephen S. ; et al.	2018-06-21
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20180008693 - Whitehead; Stephen S. ; et al.	2018-01-11
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant RE46,641 - Whitehead , et al. December 19, 2	2017-12-19
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Grant RE46,631 - Whitehead , et al. December 12, 2	2017-12-12
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein Grant 9,707,287 - Whitehead , et al. July 18, 2	2017-07-18
Development of dengue virus vaccine components Grant RE46,042 - Whitehead , et al. June 28, 2	2016-06-28
Development of dengue virus vaccine components Grant 9,090,873 - Whitehead , et al. July 28, 2	2015-07-28
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20150064214 - Whitehead; Stephen S. ; et al.	2015-03-05
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20140294892 - Pletnev; Alexander G. ; et al.	2014-10-02
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis Grant RE45,123 - Whitehead , et al. September 9, 2	2014-09-09
Multivalent Vaccines For Rabies Virus And Filoviruses App 20140212434 - Blaney; Joseph E. ; et al.	2014-07-31
Attenuated dengue virus comprising mutations in the NS3 gene Grant RE45,053 - Whitehead , et al. July 29, 2	2014-07-29
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant RE45,016 - Whitehead , et al. July 15, 2	2014-07-15
Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3' untranslated region Grant 8,632,782 - Whitehead , et al. January 21, 2	2014-01-21
Development Of Dengue Virus Vaccine Components App 20130089567 - Whitehead; Stephen S. ; et al.	2013-04-11
Development of dengue virus vaccine components Grant 8,337,860 - Whitehead , et al. December 25, 2	2012-12-25
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20120114694 - Whitehead; Stephen S. ; et al.	2012-05-10
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis Grant 8,039,003 - Whitehead , et al. October 18, 2	2011-10-18
Chimeric Sle/dengue Type 4 Antigenic Viruses App 20100316670 - Blaney; Joseph E. ; et al.	2010-12-16
Development Of Dengue Virus Vaccine Components App 20100104598 - Whitehead; Stephen S. ; et al.	2010-04-29
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses App 20090263424 - Whitehead; Stephen S. ; et al.	2009-10-22
Attenuated dengue virus comprising mutations in the NS3 gene Grant 7,560,118 - Whitehead , et al. July 14, 2	2009-07-14
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Grant 7,226,602 - Whitehead , et al. June 5, 2	2007-06-05
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses App 20070092534 - Whitehead; Stephen S. ; et al.	2007-04-26
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses App 20050010043 - Whitehead, Stephen S. ; et al.	2005-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.